FF vs REGN
FutureFuel Corp (FF) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
FutureFuel Corp (FF) is a specialty chemicals company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FF revenue for 2024-12-31 was $243.3M. Net income was $15.5M. Revenue was up 164.5% from 2023-12-31 to 2024-12-31. FF currently screens at market cap $185.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FF currently screens at market cap $185.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FF and REGN stock pages for the full models.
Not investment advice.